20-day avg volume: 1K shares
- Stock trades at a high P/E of 52.
| Metric | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sept 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sept 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sept 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sept 2020 | Jun 2020 | Mar 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹938 Cr | ₹1,260 Cr | ₹1,149 Cr | ₹935 Cr | ₹989 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EBITDA | ₹209 Cr | ₹392 Cr | ₹275 Cr | ₹257 Cr | ₹199 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net Profit | ₹153 Cr | ₹301 Cr | ₹210 Cr | ₹192 Cr | ₹156 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EPS | 47.17 | 92.87 | 64.65 | 59.17 | 48.09 | 82.74 | 65.28 | 24.97 | 47.56 | 70.51 | 64.91 | 46.59 | 50.84 | 63.91 | 47.57 | 13.11 | 31.68 | 65.33 | 67.25 | 15.09 | 30.29 | 77.21 | 78.21 | 21.32 | 28.07 |
| Metric | Mar 2026 | Jun 2025 | Mar 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹4,290 Cr | ₹4,311 Cr | ₹0 Cr | ₹4,206 Cr | ₹3,918 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net Profit | ₹857 Cr | ₹829 Cr | ₹0 Cr | ₹675 Cr | ₹678 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EPS | — | — | 196.11 | — | — | 177.37 | 200.79 | 133.42 |
| Metric | Mar 2026 | Mar 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|---|---|
| Total Assets | ₹1,804 Cr | ₹0 Cr | ₹1,859 Cr | ₹2,137 Cr | ₹1,683 Cr | ₹0 Cr | ₹0 Cr |
| Total Liabilities | ₹1,050 Cr | ₹0 Cr | ₹1,084 Cr | ₹1,191 Cr | ₹945 Cr | ₹0 Cr | ₹0 Cr |
| Equity | ₹753 Cr | ₹0 Cr | ₹775 Cr | ₹946 Cr | ₹738 Cr | ₹0 Cr | ₹0 Cr |
| Total Debt | ₹1 Cr | ₹0 Cr | ₹3 Cr | ₹4 Cr | ₹5 Cr | ₹0 Cr | ₹0 Cr |
| Metric | Mar 2026 | Mar 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
| Operating | ₹924 Cr | ₹0 Cr | ₹471 Cr | ₹826 Cr | ₹573 Cr | ₹0 Cr |
| Investing | ₹11 Cr | ₹0 Cr | ₹1 Cr | ₹-10 Cr | ₹-27 Cr | ₹0 Cr |
| Financing | ₹-845 Cr | ₹0 Cr | ₹-862 Cr | ₹-477 Cr | ₹-569 Cr | ₹0 Cr |
| Free Cash Flow | ₹875 Cr | ₹0 Cr | ₹426 Cr | ₹781 Cr | ₹523 Cr | ₹0 Cr |
FMCG · Personal Care - Multinational
Procter & Gamble Hygiene and Health Care Limited manufactures and sells branded packaged fast-moving consumer goods in the feminine care and healthcare businesses in India and internationally. It operates through Health care Products and Hygiene Products segments. The company offers health care products, including ointments and creams, cough drops, and tablets; and hygiene products, such as feminine hygiene and other skin care hygiene products, as well as feminine care pads. It also provides baby care products comprising nappies, pants, and baby wipes; grooming products; laundry products; hair care products; home, personal and skin care, and oral products. The company sells its products under the Vicks, Whisper, Pampers, Ariel, Tide, Gillette, Head & Shoulders, Herbal Essences, Pantene, Ambi Pur, Oral-B, Olay, and Old Spice brands through mass merchandisers, as well as grocery, membership club, drug, department, and high frequency stores. The company was incorporated in 1964 and is based in Mumbai, India. Procter & Gamble Hygiene and Health Care Limited operates as a subsidiary of The Procter & Gamble Company.
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search
